For the year ending 2025-12-31, ETON made $79,950K in revenue. -$4,601K in net income. Net profit margin of -5.75%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total net revenues | 79,950 | |||
| License | 825 | |||
| Product Sales And Royalties | 36,385 | |||
| Total cost of sales | 37,210 | |||
| Gross profit | 42,740 | |||
| Research and development | 7,765 | |||
| General and administrative | 35,819 | |||
| Total operating expenses | 43,584 | |||
| Loss from operations | -844 | |||
| Interest and other (expense) income, net | -3,714 | |||
| Loss before income tax expense | -4,558 | |||
| Income tax expense | 43 | |||
| Net loss | -4,601 | |||
| Basic EPS | -0.17 | |||
| Basic Average Shares | 26,908,000 | |||
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON)